SCHEMBL4757358

SCHEMBL4757358

CCCc1csc(NC(=O)c2ccc(C)c(Cl)c2)n1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
ALDH1A1 P00352 2/20 0.49
SCD O00767 1/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
GCK P35557 1/20 0.48
GRM5 P41594 1/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
LMNA P02545 3/20 0.47
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
MAPK1 P28482 2/20 0.47
HTT P42858 1/20 0.47
HPGD P15428 1/20 0.47
NFKB1 P19838 1/20 0.47
NFKB2 Q00653 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4757054 0.85 PDE5A (0.47) MAPTCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL4757092 0.80 MAPK1 (0.60) MAPTCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL4757309 0.79 NPC1 (0.47) MAPTCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL20662872 0.78 MAPT (0.64) MAPTSCDMEN1KMT2ASMN1; SMN2
SCHEMBL4757218 0.77 STAT3 (0.48) MAPTCYP1A2CYP3A4CYP2C19ALDH1A1
SCHEMBL9570944 0.72 SMN1; SMN2 (0.69) ALDH1A1KMT2ASMN1; SMN2LMNANPC1
SCHEMBL4932516 0.72 ALDH1A1 (0.45) MAPTCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL10114593 0.72 MAPT (0.69) MAPTALDH1A1SCDMEN1KMT2A
SCHEMBL3607419 0.71 LMNA (0.71) MAPTCYP1A2CYP2C19ALDH1A1MEN1
SCHEMBL15426988 0.71 GCK (0.69) MAPTALDH1A1SCDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC MAPT 4288/4885CYP1A2 2853/4885CYP3A4 1087/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.